CMRX
Price
$8.54
Change
-$0.01 (-0.12%)
Updated
Apr 17 closing price
Capitalization
801.08M
7 days until earnings call
FGEN
Price
$0.33
Change
+$0.02 (+6.45%)
Updated
Apr 24, 04:59 PM (EDT)
Capitalization
30.23M
18 days until earnings call
Ad is loading...

CMRX vs FGEN

Header iconCMRX vs FGEN Comparison
Open Charts CMRX vs FGENBanner chart's image
Chimerix
Price$8.54
Change-$0.01 (-0.12%)
Volume$755.56K
Capitalization801.08M
FibroGen
Price$0.33
Change+$0.02 (+6.45%)
Volume$10.45K
Capitalization30.23M
CMRX vs FGEN Comparison Chart
Loading...
CMRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
FGEN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CMRX vs. FGEN commentary
Apr 24, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CMRX is a Hold and FGEN is a Buy.

Ad is loading...
COMPARISON
Comparison
Apr 24, 2025
Stock price -- (CMRX: $8.54 vs. FGEN: $0.31)
Brand notoriety: CMRX and FGEN are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CMRX: 15% vs. FGEN: 12%
Market capitalization -- CMRX: $801.08M vs. FGEN: $30.23M
CMRX [@Biotechnology] is valued at $801.08M. FGEN’s [@Biotechnology] market capitalization is $30.23M. The market cap for tickers in the [@Biotechnology] industry ranges from $266.85B to $0. The average market capitalization across the [@Biotechnology] industry is $2.09B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CMRX’s FA Score shows that 0 FA rating(s) are green whileFGEN’s FA Score has 0 green FA rating(s).

  • CMRX’s FA Score: 0 green, 5 red.
  • FGEN’s FA Score: 0 green, 5 red.
According to our system of comparison, CMRX is a better buy in the long-term than FGEN.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CMRX’s TA Score shows that 2 TA indicator(s) are bullish while FGEN’s TA Score has 4 bullish TA indicator(s).

  • CMRX’s TA Score: 2 bullish, 1 bearish.
  • FGEN’s TA Score: 4 bullish, 3 bearish.
According to our system of comparison, both CMRX and FGEN are a good buy in the short-term.

Price Growth

CMRX (@Biotechnology) experienced а -0.12% price change this week, while FGEN (@Biotechnology) price change was +10.84% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +7.07%. For the same industry, the average monthly price growth was -6.06%, and the average quarterly price growth was -12.59%.

Reported Earning Dates

CMRX is expected to report earnings on Aug 19, 2025.

FGEN is expected to report earnings on Aug 11, 2025.

Industries' Descriptions

@Biotechnology (+7.07% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CMRX($801M) has a higher market cap than FGEN($30.2M). CMRX YTD gains are higher at: 145.402 vs. FGEN (-41.889). CMRX has higher annual earnings (EBITDA): -92.74M vs. FGEN (-101.15M). CMRX (136M) and FGEN (131M) have equal amount of cash in the bank . CMRX has less debt than FGEN: CMRX (644K) vs FGEN (79.3M). FGEN has higher revenues than CMRX: FGEN (180M) vs CMRX (159K).
CMRXFGENCMRX / FGEN
Capitalization801M30.2M2,652%
EBITDA-92.74M-101.15M92%
Gain YTD145.402-41.889-347%
P/E RatioN/AN/A-
Revenue159K180M0%
Total Cash136M131M104%
Total Debt644K79.3M1%
FUNDAMENTALS RATINGS
CMRX vs FGEN: Fundamental Ratings
CMRX
FGEN
OUTLOOK RATING
1..100
316
VALUATION
overvalued / fair valued / undervalued
1..100
92
Overvalued
94
Overvalued
PROFIT vs RISK RATING
1..100
50100
SMR RATING
1..100
94100
PRICE GROWTH RATING
1..100
3485
P/E GROWTH RATING
1..100
9643
SEASONALITY SCORE
1..100
50n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

CMRX's Valuation (92) in the Biotechnology industry is in the same range as FGEN (94). This means that CMRX’s stock grew similarly to FGEN’s over the last 12 months.

CMRX's Profit vs Risk Rating (50) in the Biotechnology industry is somewhat better than the same rating for FGEN (100). This means that CMRX’s stock grew somewhat faster than FGEN’s over the last 12 months.

CMRX's SMR Rating (94) in the Biotechnology industry is in the same range as FGEN (100). This means that CMRX’s stock grew similarly to FGEN’s over the last 12 months.

CMRX's Price Growth Rating (34) in the Biotechnology industry is somewhat better than the same rating for FGEN (85). This means that CMRX’s stock grew somewhat faster than FGEN’s over the last 12 months.

FGEN's P/E Growth Rating (43) in the Biotechnology industry is somewhat better than the same rating for CMRX (96). This means that FGEN’s stock grew somewhat faster than CMRX’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
CMRXFGEN
RSI
ODDS (%)
N/A
Bullish Trend 2 days ago
81%
Stochastic
ODDS (%)
Bearish Trend 8 days ago
88%
Bearish Trend 2 days ago
83%
Momentum
ODDS (%)
N/A
Bullish Trend 2 days ago
82%
MACD
ODDS (%)
N/A
Bullish Trend 2 days ago
88%
TrendWeek
ODDS (%)
Bullish Trend 8 days ago
75%
Bullish Trend 2 days ago
84%
TrendMonth
ODDS (%)
Bullish Trend 8 days ago
79%
Bearish Trend 2 days ago
85%
Advances
ODDS (%)
Bullish Trend 10 days ago
78%
Bullish Trend 2 days ago
86%
Declines
ODDS (%)
N/A
Bearish Trend 9 days ago
84%
BollingerBands
ODDS (%)
N/A
N/A
Aroon
ODDS (%)
Bullish Trend 8 days ago
75%
Bearish Trend 2 days ago
88%
View a ticker or compare two or three
Ad is loading...
CMRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
FGEN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
PANL4.240.19
+4.69%
Pangaea Logistics Solutions Ltd
DUOT6.140.24
+4.07%
Duos Technologies Group
GKOS92.612.88
+3.21%
Glaukos Corp
YUM146.161.11
+0.77%
Yum! Brands
ARDX4.840.03
+0.52%
Ardelyx

CMRX and

Correlation & Price change

A.I.dvisor indicates that over the last year, CMRX has been loosely correlated with QURE. These tickers have moved in lockstep 52% of the time. This A.I.-generated data suggests there is some statistical probability that if CMRX jumps, then QURE could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CMRX
1D Price
Change %
CMRX100%
N/A
QURE - CMRX
52%
Loosely correlated
N/A
NAMS - CMRX
49%
Loosely correlated
+2.86%
CRDF - CMRX
44%
Loosely correlated
-4.10%
AUPH - CMRX
37%
Loosely correlated
+2.41%
FGEN - CMRX
35%
Loosely correlated
+2.70%
More

FGEN and

Correlation & Price change

A.I.dvisor indicates that over the last year, FGEN has been loosely correlated with AVTX. These tickers have moved in lockstep 57% of the time. This A.I.-generated data suggests there is some statistical probability that if FGEN jumps, then AVTX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To FGEN
1D Price
Change %
FGEN100%
+2.70%
AVTX - FGEN
57%
Loosely correlated
+1.64%
AXON - FGEN
43%
Loosely correlated
+3.82%
BMRN - FGEN
41%
Loosely correlated
+0.72%
INSM - FGEN
39%
Loosely correlated
-0.70%
CMRX - FGEN
35%
Loosely correlated
N/A
More